News

Home > News > News

2026/02/24

CCSB obtained US. patent: Crystal Form A、B、C、D、E、F and G of Selumetinib Sulfate.

The United States Patent and Trademark Office has granted Chunghwa Chemical Synthesis & Biotech Co. Ltd (CAS/CCSB) a patent of Crystal Forms ABCDEF and G of Selumetinib Sulfate and Preparation Methods Thereof. (Patent no. US 12,552,751 B2) on 17th February, 2026.